Great Point Partners as of June 30, 2025
Portfolio Holdings for Great Point Partners
Great Point Partners holds 26 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 12.8 | $20M | 500k | 39.51 | |
| Rezolute Com New (RZLT) | 8.8 | $14M | 3.0M | 4.46 | |
| Amylyx Pharmaceuticals (AMLX) | 8.3 | $13M | 2.0M | 6.41 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 8.1 | $12M | 350k | 35.49 | |
| Abivax Sa Sponsored Ads (ABVX) | 6.4 | $9.9M | 1.3M | 7.65 | |
| Neurogene (NGNE) | 4.7 | $7.3M | 486k | 14.95 | |
| Akebia Therapeutics (AKBA) | 4.7 | $7.2M | 2.0M | 3.64 | |
| Evolus (EOLS) | 4.3 | $6.6M | 720k | 9.21 | |
| Arcellx Common Stock (ACLX) | 4.3 | $6.6M | 100k | 65.85 | |
| Xenon Pharmaceuticals (XENE) | 4.1 | $6.3M | 200k | 31.30 | |
| Akero Therapeutics (AKRO) | 3.6 | $5.5M | 104k | 53.36 | |
| Jade Biosciences Com New (JBIO) | 3.2 | $5.0M | 498k | 9.99 | |
| Cytokinetics Com New (CYTK) | 3.2 | $5.0M | 150k | 33.04 | |
| Immunovant (IMVT) | 2.7 | $4.2M | 262k | 16.00 | |
| Unicycive Therapeutics Com New (UNCY) | 2.5 | $3.8M | 797k | 4.77 | |
| Kalvista Pharmaceuticals (KALV) | 2.4 | $3.7M | 323k | 11.30 | |
| Taysha Gene Therapies Com Shs (TSHA) | 2.3 | $3.5M | 1.5M | 2.31 | |
| Dbv Technologies S A Sponsored Ads (DBVT) | 2.2 | $3.4M | 375k | 9.16 | |
| Zura Bio Class A Ord Shs (ZURA) | 2.2 | $3.3M | 3.2M | 1.05 | |
| Upstream Bio (UPB) | 2.1 | $3.3M | 300k | 10.98 | |
| Context Therapeutics (CNTX) | 2.0 | $3.1M | 4.7M | 0.66 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.9 | $3.0M | 225k | 13.14 | |
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $2.2M | 62k | 35.42 | |
| Promis Neurosciences Com New (PMN) | 0.8 | $1.3M | 2.6M | 0.48 | |
| Pliant Therapeutics (PLRX) | 0.6 | $986k | 850k | 1.16 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.2 | $312k | 29k | 10.62 |
